A review of the metabolic effects of sibutramine
- 21 February 2005
- journal article
- review article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 21 (3) , 457-466
- https://doi.org/10.1185/030079905x38132
Abstract
Background: Obesity is associated with an increased incidence of diabetes, hypertension, dyslipidaemia and coronary artery disease. Current management strategies of obesity include lifestyl...Keywords
This publication has 57 references indexed in Scilit:
- Clinical Pharmacotherapy for Obesity: Current Drugs and Those in Advanced DevelopmentCurrent Drug Targets, 2004
- What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventionsJournal of Human Nutrition and Dietetics, 2004
- Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvementHealth Technology Assessment, 2004
- Clinical use of sibutramineDrugs of Today, 2004
- Prevalence and Trends in Obesity Among US Adults, 1999-2000JAMA, 2002
- Modalities of the food intake-reducing effect of sibutramine in humansPhysiology & Behavior, 2000
- Sibutramine: A Serotonin–Norepinephrine Reuptake-Inhibitor for the Treatment of ObesityAnnals of Pharmacotherapy, 1999
- Investigation of the mechanisms underlying the hypophagic effects of the 5‐HT and noradrenaline reuptake inhibitor, sibutramine, in the ratBritish Journal of Pharmacology, 1997
- A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutraminePsychopharmacology, 1992
- The contribution of metabolites to the rapid and potent down-regulation of rat cortical β-adrenoceptors by the putative antidepressant sibutramine hydrochlorideNeuropharmacology, 1989